IAN KAHANE: Open Payments
NPI 1861846263 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$34,743 in 215 payments from 35 companies in 2025. Trend: 2023 $33,937 · 2024 $15,610 · 2025 $34,743
Speaker / faculty: $23,672Consulting: $4,945Food & beverage: $4,084Travel & lodging: $2,042
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 46 | $26,112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $5,404 |
| ABBVIE INC. | 15 | $397 |
| PFIZER INC. | 30 | $355 |
| Lilly USA, LLC | 18 | $331 |
| Novartis Pharmaceuticals Corporation | 11 | $324 |
| AstraZeneca Pharmaceuticals LP | 11 | $305 |
| Novo Nordisk Inc | 15 | $245 |
| Eisai Inc. | 5 | $113 |
| Gilead Sciences, Inc. | 4 | $99 |
Products named: REPATHA, OFEV, LEQVIO, AIRSUPRA, OTEZLA, VRAYLAR, NURTEC ODT, PROLIA.
Industry payments across FL — which companies pay providers there.
